Quintrio
Home

DENTAL EQUIPMENT & SUPPLIES

DENTSPLY SIRONA Inc.

XRAY

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantology. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers.

Last trade $8.69
Day change -$0.255 (-2.85%)
Day range $8.68 – $9.01
Volume 4,420,102
Market cap $1.78B

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$1.78B
Price / earnings
—
Price / book
1.32×
Price / sales
0.5×
EV / sales
1.06×
EV / EBITDA
7.39×

Profitability

Earnings per share
-$0.61
Return on assets
-2.33%
Return on equity
-8.93%
Dividend yield
3.59%

Liquidity and leverage

Debt / equity
1.62×
Current ratio
1.63×
Quick ratio
1.04×
Cash ratio
0.16×

Cash flow

Price / cash flow
6.56×
Price / free cash flow
17.32×
Free cash flow
$103M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for XRAY, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024
Revenue$836M$898M$880M$961M$904M$936M$879M$905M
Cost of revenue$393M$405M$453M$518M$463M$446M$413M$459M
Gross profit$443M$493M$427M$443M$441M$490M$466M$446M
Selling, general and administrative$363M$364M$351M$383M$355M$342M$358M$401M
Research and development$42M$45M$44M$40M$37M$37M$36M$42M
Total operating expenses$406M$411M$462M$582M$659M$618M$403M$955M
Operating income$37M$82M-$35M-$139M-$218M-$128M$63M-$509M
Interest expense-$25M-$22M-$24M-$22M-$23M-$24M-$19M-$16M
Income before taxes$26M$72M-$42M-$147M-$230M-$153M$44M-$523M
Income taxes$29M$36M-$32M-$2M$198M-$109M$25M-$95M
Net income-$3M$36M-$10M-$145M-$428M-$44M$19M-$428M
Net income attributable to common shareholders-$2M$37M-$10M-$146M-$427M-$45M$20M-$430M
EBITDA$120M$169M$111M$113M$141M$199M$151M$91M
Basic earnings per share-$0.01$0.18-$0.05-$0.73-$2.14-$0.22$0.10-$2.16
Diluted earnings per share-$0.01$0.18-$0.05-$0.73-$2.14-$0.22$0.10-$2.18

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
The Motley Fool

Dentsply Sirona: 3 Key Takeaways for Long-Term Investors

Dentsply Sirona lowered its full-year 2026 sales guidance to $3.5 billion and reduced adjusted EPS to $1.20-$1.30 due to weakness in dental equipment demand and higher distribution costs. The company is investing heavily in clinical education programs in North America and building sales teams for dental support organizations. Wellspect Healthcare showed positive momentum with 10% revenue growth to $92 million, while management prioritizes debt reduction alongside disciplined reinvestment in commercial execution.

Zacks Investment Research

New Strong Sell Stocks for November 13th

Three companies have been added to the Zacks Rank #5 (Strong Sell) list today due to downward revisions in earnings estimates over the past 60 days. DENTSPLY SIRONA, a medical devices company, saw an 11% downward revision. Dutch Bros, a drive-thru restaurant operator, experienced a 5.2% downward revision. Great Elm Capital Corp., a business development company, faced a 5.5% downward revision.

Zacks Investment Research

Dentsply (XRAY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Dentsply International reported Q3 2026 revenue of $836 million, down 7.5% year-over-year and missing Wall Street's consensus estimate of $855.98 million by 2.34%. EPS came in at $0.29 versus the estimated $0.30, representing a 3.33% miss. Key business segments showed mixed results, with Americas sales beating estimates but Connected Technology Solutions and Orthodontic and Implant Solutions significantly underperforming. The stock carries a Zacks Rank #4 (Sell) rating.

GlobeNewswire Inc.

ANZ Dental Implants Market Report: Size, Share, Trends, Forecast 2026-2033 | Market to Reach US$393 Million as Aging and Prosthetics Demand Drive 5% CAGR

The ANZ dental implants market is valued at USD 266.0 million in 2025 and is projected to reach USD 393.0 million by 2033, growing at a 5.0% CAGR. Growth is driven by aging populations, increased demand for prosthetics, and technological advances in implant materials. However, high treatment costs remain a significant barrier to market expansion, with 28% of Australians delaying dental care due to affordability concerns.

Zacks Investment Research

Dentsply Sirona Expands U.S. Digital Dentistry Reach With Midwest Deal

Dentsply Sirona announced an expanded distribution agreement with Midwest Dental Equipment & Supply effective November 1, 2026, to offer its digital dentistry technology portfolio across the U.S. This marks the company's seventh North American dealer partnership enhancement in 2026, aimed at broadening access to connected technology solutions and accelerating digital dentistry adoption. XRAY stock gained 3.6% following the announcement.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

Ex-dividendAmount / sharePay dateType
Dec 26, 2025$0.16Jan 9, 2026recurring
Sep 26, 2025$0.16Oct 10, 2025recurring
Jun 27, 2025$0.16Jul 11, 2025recurring
Mar 28, 2025$0.16Apr 11, 2025recurring
Dec 27, 2024$0.16Jan 10, 2025recurring

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Jul 18, 20062-for-1forward split